Table 1.
Healthcare institution | Genes implemented | Associated drugs |
---|---|---|
St. Jude Children’s Research Hospitala | TPMT/NUDT15 | Thiopurines |
CYP2C9 | Celecoxib | |
CYP2C19 | Clopidogrel, amitriptyline, clomipramine, imipramine, trimipramine, doxepin, voriconazole, PPIs | |
CYP2D6 | Codeine, oxycodone, tramadol, amitriptyline, clomipramine, imipramine, trimipramine, doxepin, fluoxetine, paroxetine, ondansetron, | |
CYP3A5 | Tacrolimus | |
DPYD | Fluoropyrimidines | |
SLCO1B1 | Simvastatin | |
UGT1A1 | Atazanavir | |
mt-RNR1 | Aminoglycoside antibiotics | |
RYR1/CACNA1S | Succinylcholine and volatile fluorinated anesthetics | |
Children’s Minnesotab | TPMT/NUDT15 | Thiopurines |
CYP2C9 | Phenytoin, fosphenytoin | |
CYP2C19 | Citalopram, escitalopram, amitriptyline, clomipramine, imipramine, trimipramine, doxepin, voriconazole | |
CYP2D6 | Atomoxetine, aripiprazole, amitriptyline, clomipramine, imipramine, trimipramine, doxepin, desipramine, nortriptyline, paroxetine, fluvoxamine, ondansetron, tramadol | |
CYP3A5 | Tacrolimus | |
DPYD | 5-Fluorouracil | |
RYR1/CACNA1S | Succinylcholine and volatile fluorinated anesthetics | |
University of Florida in partnership with Nemours Children’s Specialty Care, Jacksonville, FL and Nemours Children’s Hospital, Orlando, FLc | TPMT/NUDT15 | Thiopurines |
CYP2C19 | PPIs | |
Boston Children’s Hospitald | TPMT/NUDT15 | Thiopurines |
CYP2C9 | Phenytoin, fosphenytoin, glimepiride, glipizide, glipizide-metformin, glyburide, glyburide-metformin, glimepiride-pioglitazone, glimepiride-rosiglitazone, irbesartan, hydrochlorothiazide-irbesartan, losartan, hydrochlorothiazide-losartan, tolbutamide, warfarin | |
CYP2C19 | Amitriptyline, amitriptyline/chlordiazepoxide, amitriptyline/perphenazine, citalopram, clobazam, clomipramine, clopidogrel, doxepin, escitalopram, esomeprazole, esomeprazole/naproxen, imipramine, lansoprazole, lansoprazole/amoxicillin/clarithromycin, lansoprazole/naproxen, omeprazole, omeprazole/sodium bicarbonate, omeprazole/clarithromycin/amoxicillin, pantoprazole, rabeprazole, sertraline, voriconazole | |
VKORC1 | Warfarin | |
HLA-A | Carbamazepine | |
HLA-B | Abacavir, allopurinol, carbamazepine, fosphenytoin, oxcarbazepine, phenytoin | |
Cincinnati Children’s Hospital Medical Centere | TPMT/NUDT15 | Thiopurines |
CYP2C19 | Amitriptyline, clomipramine, imipramine, trimipramine, doxepin, clopidogrel, voriconazole, PPIs | |
CYP2D6 | Codeine, hydrocodone, oxycodone, tramadol, aripiprazole, haloperidol, olanzapine, perphenazine, risperidone, thioridazine, amitriptyline, clomipramine, imipramine, trimipramine, doxepin, desipramine, maprotiline, nortriptyline, fluoxetine, paroxetine, fluvoxamine, venlafaxine |
aHaidar et al. [15].
bUnpublished data, courtesy of D Gregornik, PharmD, Children’s Minnesota.
cWeitzel et al. [19] and Cicali et al. [20].
dManzi et al. [13] and Kim et al. [46].
eRamsey et al. [21], https://www.cincinnatichildrens.org/service/g/genetic-pharmacology/education, accessed 20 Nov 2019.